Total income during the reported quarter stood at ₹436.93 crore, up 2.22 per cent as against ₹427.42 crore in the corresponding period a year ago, Jyothy Labs said in a regulatory filing.
Its expenses in the quarter under review stood at ₹375.96 crore, down 0.39 per cent, compared with ₹377.46 crore reported in the first quarter of the previous fiscal.
Jyothy Labs Managing Director M R Jyothy said: "We began this quarter with an uncertain business environment due to COVID-19 with restrictions on the supply side, however, our team with flawless execution combined with our portfolio comprising of daily use 'essential hygiene' has delivered positive sales growth.
"With our differentiated product offerings, wide distribution network and innovative thought process, we are confident of meeting our consumer demands and deliver to our stakeholders' expectations."
Jyothy Labs said due to the spread of COVID-19 from mid-March and consequent nationwide lockdown, the business operations were suddenly disrupted across the country.
"The company quickly aligned its manufacturing operations, sales team to the new working environment. We are currently operating at near pre-COVID levels capacity utilisation," it added.